Arrhythmia Services, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
Expert Rev Med Devices. 2014 Jul;11(4):375-81. doi: 10.1586/17434440.2014.916207. Epub 2014 May 3.
Robotic systems allow for mapping and ablation of different arrhythmia substrates replacing hand maneuvering of intracardiac catheters with machine steering. Currently there are four commercially available robotic systems. Niobe magnetic navigation system (Stereotaxis Inc., St Louis, MO) and Sensei robotic navigation system (Hansen Medical Inc., Mountain View, CA) have an established platform with at least 10 years of clinical studies looking at their efficacy and safety. AMIGO Remote Catheter System (Catheter Robotics, Inc., Mount Olive, NJ) and Catheter Guidance Control and Imaging (Magnetecs, Inglewood, CA) are in the earlier phases of implementations with ongoing feasibility and some limited clinical studies. This review discusses the advantages and limitations related to each existing system and highlights the ideal futuristic robotic system that may include the most promising features of the current ones.
机器人系统允许对不同的心律失常基质进行映射和消融，用机器引导取代了手动操纵心内导管。目前有四个商业上可用的机器人系统。Niobe 磁导航系统（Stereotaxis Inc.，密苏里州圣路易斯）和 Sensei 机器人导航系统（Hansen Medical Inc.，加利福尼亚州山景城）拥有至少 10 年的临床研究，以评估其疗效和安全性，已经确立了其平台地位。AMIGO 远程导管系统（Catheter Robotics，Inc.，新泽西州芒特奥利夫）和导管引导控制和成像（Magnetecs，加利福尼亚州英格尔伍德）处于实施的早期阶段，正在进行可行性和一些有限的临床研究。本文讨论了与每个现有系统相关的优点和局限性，并强调了理想的未来机器人系统，该系统可能包括当前系统最有前途的功能。
